Insulet | PODD - 流动资产



金融业
股票价格
USD
资产
USD 3.17B
现金及等价物
USD 534.9M
销售成本
USD 239.1M
流动资产
USD 1.85B
流动负债
USD 744.2M
债务
USD 948.4M
EBIT
USD 129.7M
EBITDA
USD 199.8M
员工
3.9K
EPS每股收益
USD 1.66
股本和储备
USD 1.42B
销售毛利
USD 562.6M
债务利息支出
USD 11M
利息收入
USD 4.9M
贷款资金
USD 929.5M
市值
USD 10.3B
净收入
USD 95M
营业费用
USD 672M
营业利润
USD 129.7M
普通股股本
USD 69.35M
PE价格收益
29.66
税前利润
USD 118.7M
销售收入
USD 801.7M
销售和管理费用
USD 344.8M
股票
USD 484.8M
贸易债权人
USD 123.3M
应收帐款人
USD 588.7M


流动资产 更改 日
Abbott USD 25.51B 488M 2026-03
Align Technology USD 2.66B 7.62M 2026-06
AtriCure USD 345.53M 31.84M 2026-06
Baxter International USD 6.99B 142M 2026-06
Becton, Dickinson and Co. USD 8.14B 127M 2026-06
Boston Scientific USD 7.97B 712M 2026-06
Cardinal Health USD 38.75B 689M 2026-06
Cooper Companies USD 2.3B 166M 2026-03
Dexcom USD 4.09B 245.1M 2026-06
Edwards Lifesciences USD 6.82B 590.2M 2026-06
Eli Lilly USD 64.67B 9.84B 2026-06
Globus Medical USD 2.22B 17.39M 2026-06
ICU Medical USD 1.21B 2.34M 2026-06
Inogen USD 203.72M 594K 2025-09
Insulet USD 1.85B 139.6M 2026-06
Integra LifeSciences USD 1.19B 19.46M 2026-06
J&J USD 59.77B 601M 2026-06
Medtronic USD 24.79B 716M 2026-03
Merit Medical Systems USD 1.11B 10.46M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
Solventum Corp USD 3.74B 158M 2026-06
Stryker USD 14.42B 1.08B 2026-06
Tandem Diabetes Care USD 804.64M 82.46M 2026-06
Teleflex USD 1.88B 16.21M 2026-06
West Pharmaceutical Services USD 1.81B 19.3M 2026-06
Zimmer Biomet Holdings USD 5.1B 134.2M 2026-06